Seasoned operator and investor focusing on growth-stage technology and financial services companies, with experience scaling teams, leading product strategy, and executing M&A. David Vollmer combines operating leadership with active angel and venture investing, serving on private company boards and advising founders on capital strategy and go-to-market. Market-oriented, sector-savvy profile valued by LPs and co-investors.
Seasoned operator and investor focusing on growth-stage technology and financial services companies, with experience scaling teams, leading product strategy, and executing M&A. David Vollmer combines operating leadership with active angel and venture investing, serving on private company boards and advising founders on capital strategy and go-to-market. Market-oriented, sector-savvy profile valued by LPs and co-investors.
Combines operator-led venture investing with a growth-stage, market-oriented playbook focused on fintech and enterprise software. Prioritizes capital into companies demonstrating durable unit economics, repeatable go-to-market motion, and product-led differentiation. Favors active board engagement, tight KPI-driven governance, and staged capital deployment tied to commercial milestones. Time horizon is multi-year growth scaling to exit via strategic sale or IPO; risk is managed through concentrated conviction positions supplemented by diversification across stages and co-investor syndicates. Decision-making blends founder-first judgment with data-driven underwriting and M&A-aware return planning.
Combines operator-led venture investing with a growth-stage, market-oriented playbook focused on fintech and enterprise software. Prioritizes capital into companies demonstrating durable unit economics, repeatable go-to-market motion, and product-led differentiation. Favors active board engagement, tight KPI-driven governance, and staged capital deployment tied to commercial milestones. Time horizon is multi-year growth scaling to exit via strategic sale or IPO; risk is managed through concentrated conviction positions supplemented by diversification across stages and co-investor syndicates. Decision-making blends founder-first judgment with data-driven underwriting and M&A-aware return planning.
| Trades 4260 | Longs Won 2741/4260 64% | Profit Factor 4.43 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $160,645.93 |
| Average Win $24,400.26 | Best Trade (Oct 26) $4.61M | Sharpe Ratio -99.96 |
| Average Loss -$9,945.33 | Worst Trade (Oct 23) -$1.89M | Z-Score 15.79 (100%) |
| Commissions $0 | Avg. Trade Length 1y 10m 2w 4d | Expectancy $12,153.56 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 25,000 | 22,500 | 20,000 | 17,500 | 15,000 | 12,500 | 10,000 | 7,500 | 5,000 | 2,500 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAL American Airlines Group Inc. | 135 | $1,625.47 | $1,651.05 | - | $25.58 | 1.57% | +0.991% |
AAPL Apple Inc. | 9,788 | $2.02M | $3.36M | - | $1.35M | 66.85% | -1.163% |
AB AllianceBernstein Holding L.P. | 190 | $6,597.17 | $6,698.45 | - | $101.28 | 1.54% | +0.93% |
ABBV AbbVie Inc. | 1,843 | $348,290.55 | $527,024.26 | - | $178,733.71 | 51.32% | +0.112% |
ABT Abbott Laboratories | 1,507 | $156,453.89 | $156,743.07 | - | $289.18 | 0.18% | +0.299% |
ACB Aurora Cannabis Inc. | 5,750 | $25,908.58 | $22,553.22 | - | -$3,355.36 | -12.95% | +1.09% |
ACN Accenture plc | 39 | $11,197.1 | $9,538.23 | - | -$1,658.87 | -14.82% | -1.925% |
ADI Analog Devices, Inc. | 378 | $77,077.58 | $154,443.24 | - | $77,365.66 | 100.37% | +4.477% |
ADNT Adient plc | 4 | $196.73 | $67.18 | - | -$129.55 | -65.85% | +1.114% |
ADP Automatic Data Processing Inc. | 59 | $13,825.33 | $17,694.69 | - | $3,869.36 | 27.99% | -1.397% |
AEP American Electric Power Company, Inc. | 504 | $68,879.38 | $65,215.08 | - | -$3,664.3 | -5.32% | -0.227% |
AFL Aflac Incorporated | 181 | $20,227 | $21,945.34 | - | $1,718.34 | 8.5% | +0.61% |
AGIX KraneShares Public-Private AI & Technology ETF | 5 | $235 | $219.95 | - | -$15.05 | -6.4% | +1.852% |
AIG American International Group, Inc. | 71,668 | $5.51M | $5.81M | - | $296,816.74 | 5.38% | -0.209% |
AIQ Global X Artificial Intelligence & Technology ETF | 420 | $19,985.3 | $26,497.8 | - | $6,512.5 | 32.59% | +1.284% |
AJG Arthur J. Gallagher & Co. | 4 | $1,239 | $1,058.14 | - | -$180.86 | -14.6% | -1.308% |
AKAM Akamai Technologies, Inc. | 32 | $2,553 | $3,144.96 | - | $591.96 | 23.19% | +5.079% |
ALL The Allstate Corporation | 186 | $26,288.3 | $47,575.08 | - | $21,286.78 | 80.97% | +1.023% |
ALLE Allegion plc | 63 | $7,749.49 | $11,198.88 | - | $3,449.39 | 44.51% | -0.682% |
AMAT Applied Materials Inc. | 42 | $20,492.33 | $16,446.99 | - | -$4,045.34 | -19.74% | +3.805% |